[email protected]  ·  +86 133 2121 6666 FDA / CE / RoHS / SGS certified
Clinical Solution

Nevus of Ota

Nevus of Ota is dermal melanocytosis. Blue-grey to slate-brown pigment sitting in the dermis along the upper trigeminal distribution, usually down one side of the face, and often taking the sclera with it. Clinicians also call it oculodermal melanocytosis. For equipment selection, one word in that description does all the work: dermal. The melanocytes live below the epidermis. Nothing topical reaches them, and nothing ablative reaches them without wrecking the skin on top first.

It isn't rare in the markets most of our buyers serve. DermNet puts prevalence at roughly 0.2 to 0.6 percent of Japanese people, notes it turns up more often in women, and calls it uncommon in lighter-skinned patients. Our internal disease atlas splits the caseload about evenly: half congenital, half acquired during adolescence. Lesions run from a few millimetres across to a patch covering most of a cheek. They don't itch. They don't elevate. They don't fade with the seasons and they don't resolve on their own.

So read this as a specification note. It covers what wavelength and pulse width the indication actually demands, where the single-pulse energy floor sits, how spot diameter changes reach, and which platforms on this site clear the bar. General equipment information only - not medical advice, and no substitute for a dermatologist's assessment of an individual patient.

The clinical approach

Depth sets the wavelength

Penetration scales with wavelength. Our engineering training material states it flatly: the longer the wavelength, the deeper light travels into skin. That's the whole argument for 1064 nm here, and the whole argument against 532 nm. Green light gets absorbed high up. Useful for red ink and superficial marks. Useless against pigment parked in the dermis.

Alexandrite at 755 nm and ruby at 694 nm treat this lesion too - DermNet lists all three wavelengths - but both sit shorter on the spectrum and both are absorbed harder by epidermal melanin. On Fitzpatrick IV skin and above, that trade-off gets expensive fast.

Nanoseconds, not milliseconds

Wavelength gets you to the target. Pulse width decides what happens once you're there. Anderson and Parrish set out selective photothermolysis in Science back in 1983: keep the pulse shorter than the target's thermal relaxation time and the damage stays inside the target instead of leaking into the neighbourhood.

Our training notes make the point with arithmetic anyone can check. Take a 200 mJ Nd:YAG pulse. Without Q-switching it runs around 400 microseconds. Q-switch it down to 10 nanoseconds and the energy hasn't changed by a single millijoule - but the duration fell by a factor of forty thousand, so peak power rises by that same factor. That spike fractures the melanosome mechanically. Almost no bulk heating, almost no coagulation. The fragments then leave through phagocytes and the lymphatic system over the following weeks, which is exactly why clearance is slow, and why compressing the calendar buys you nothing.

Our LN-01 emits the same 1064 nm and is completely wrong for this job. Millisecond pulses heat in bulk. Great for follicles and vessels. Hopeless for shattering pigment. Same wavelength, different physics.

Spot size is a depth control, not a speed control

Operators coming from IPL tend to treat spot diameter as a coverage setting. It isn't. Fluence is energy divided by spot area, so opening the spot at fixed energy drops your fluence. Hold fluence constant, though, and a wider beam scatters less at its edges and reaches deeper. Our operator manuals put a hard line in the text: for dermal pigment, work above 2 mm. Sub-2 mm spots belong on junctional nevi and scars, not on this.

The same manuals add a rule that follows from the first - for dermal targets, favour the higher energy density. Deep pigment doesn't respond to timid settings. It just absorbs them.

Treatment protocol

Course length and spacing

Plan a year. Probably longer. Aurangabadkar's review in the Journal of Cutaneous and Aesthetic Surgery describes multiple sessions as the norm - generally six to ten or more - with a minimum of two to three months between them. That gap isn't caution for its own sake. The macrophages need the time to clear what you fractured.

Congenital lesions usually run longer than the ones that surfaced at fourteen. Say so during the sales conversation, because a clinic that promised four sessions has an angry patient and a refund argument by month eight.

Technique and endpoint

  • Perpendicular handpiece. Ninety degrees to the skin, every shot. Our manuals are explicit about it.
  • Single pass. The same published review warns that stacking passes drives guttate hypopigmentation, mottling, blistering and scarring.
  • Overlap about one third of the spot. Enough for even coverage. Not enough to double-dose tissue.
  • Read the endpoint. Pigment lightening at the shot is the signal that fluence is adequate, per our manuals. Obvious oozing or swelling means you overshot.
  • Test first. Three to five shots at low energy, then read the response before committing to a pass.
  • Plan the anaesthesia. Our documentation recommends local anaesthesia once single-pulse energy passes roughly 300 mJ over a large field - and nevus of Ota is routinely more than half a face.

What goes wrong, and who you turn away

Post-inflammatory hyperpigmentation is the usual complication, and it's likelier on darker skin because epidermal melanin competes for the beam. We handle it separately under post-inflammatory hyperpigmentation. Recurrence after apparent clearance is common, per DermNet, and the returning pigment is sometimes darker than the original lesion. Our own atlas records complications as uncommon when an experienced doctor works with adequate equipment, and that qualifier is doing a lot of work.

Screening matters as much as settings do. Our manuals exclude patients with pacemakers or implanted defibrillators, severe diabetes, hypertension, cardiac disease or epilepsy, anyone who used functional cosmetics in the past month, and any field with broken skin, active herpes, scarring or a suspicious lesion. Periocular and scleral pigment wants an ophthalmologist's opinion rather than a laser operator's - DermNet records that ocular melanoma has rarely been reported alongside this condition, and a pigment laser does nothing about that risk either way. Strict sun protection between visits is not optional. None of this replaces clinical judgement; it's the baseline our documentation asks of a trained operator.

Recommended equipment

The energy floor nobody prints on a brochure

Our internal disease atlas carries an instruction you won't find on a competitor's spec sheet: a Q-switched unit whose single-pulse output sits below 200 mJ should not be used on nevus of Ota at all. Four reasons are listed - no significant effect, a longer course with more sessions, raised risk of post-treatment scarring, and more pain during treatment. Treat 200 mJ as a floor rather than a target. A machine quoting 150 mJ at an attractive price is quoting a different indication.

The same archive names the characteristics that matter for this lesion: continuously adjustable single-pulse energy so fluence can be tuned at a fixed spot, genuinely short pulse width, and enough single-pulse energy that the operator can open the spot instead of crawling across a cheek at 1 mm.

QE-01 or QN-03

The QE-01 is the electro-optic build. A polarizer and a voltage-driven crystal shutter sit inside the resonator and hold pulse width at 6 ns wherever you set energy, so turning energy up raises the peak power of one pulse rather than adding pulses. Output reaches 800 mJ (≤800 mJ) at 1064 nm, the spot is continuously adjustable from 1 to 7 mm through a seven-joint articulated arm, and repetition runs 1 to 10 Hz. That continuous spot adjustment earns its keep on a lesion whose depth varies across a single cheek.

The QN-03 is passively Q-switched, and energy adjustment there works by changing pulse count instead of single-pulse peak power. You get 400 mJ single at 1064 nm, stacking to roughly 800 mJ double and 1200 mJ triple, 6 to 8 ns, seven fixed spots from 1 to 4 mm, 1 to 5 Hz, no arm in the beam path. Cheaper to buy, cheaper to keep aligned. Both platforms clear the 200 mJ floor with room to spare, and both also cover tattoo removal and cautious melasma protocols - which is usually what makes either one financeable in a mixed caseload.

Acceptance, safety and consumables

At acceptance, check that the CE technical file references IEC 60601-2-22, the particular standard for surgical, cosmetic, therapeutic and diagnostic laser equipment, now in its fourth edition dated 2019. Then physically test the interlock, the key switch, the emergency stop and the footswitch before anyone signs anything. Goggles need to cover 200 to 1080 nm: the 532 nm arm is visible green and dazzling, the 1064 nm arm is invisible and worse. Keep reflective surfaces out of the room and post a warning at the door.

On consumables, water-cooled cavities want their purified-water fill maintained on the interval printed in the manual, and lamp life is the recurring cost buyers most often forget to model. Our service page covers what ships in the spares kit. Want the pigment-case parameter log template before your install date? Ask us and it goes out with the quotation.

Frequently asked questions

Can nevus of Ota be cleared completely?

Plenty of patients reach strong, durable lightening with a full Q-switched 1064 nm course, and some end up with a mark that's hard to spot. Guaranteeing a cure is another matter. Depth, colour and skin type all move the outcome, and DermNet points out that recurrence after apparent clearance is common, occasionally darker than the original. Sell meaningful improvement across a long course, with touch-ups planned in. Not a cure.

How many sessions should a clinic quote?

The published review in the Journal of Cutaneous and Aesthetic Surgery describes six to ten sessions or more as typical, with a minimum of two to three months between them. Congenital lesions generally need more than acquired ones. Anyone quoting a fixed number before seeing the lesion is guessing, and the guess usually lands short.

Why can't I use a cheaper Q-switched machine under 200 mJ?

Because it fails the indication. Our archive is blunt: below 200 mJ single-pulse, expect no significant effect, a longer course with more visits, a higher chance of scarring afterwards, and more pain during each pass. You'd be buying a device for superficial marks and calling it a dermal pigment platform. Different machine, different job.

Does the 532 nm output help with this lesion?

Not directly. 532 nm is absorbed high in the skin and aims at red and superficial brown targets, which is why our manuals map it to red ink while sending blue, black and green-blue to 1064 nm. Still worth having on the platform, since patients rarely arrive with only one pigment problem. But the dermal work is 1064 nm work.

Is it safe on Fitzpatrick V skin?

With a trained operator, yes - carefully. More epidermal melanin means more competition for the beam and a higher chance of post-inflammatory hyperpigmentation. DermNet says plainly that laser treatment of dermal melanocytosis works better on light skin than on dark. Conservative starting fluence, a test area, one pass only, longer intervals and strict photoprotection are what close the gap. Patient selection matters as much as the specification does.

References

  1. DermNet - Naevus of Ota, Hori naevus, naevus of Ito, dermal melanocytosis
  2. Aurangabadkar SJ. Assessment of the Response and Improving Outcomes of Nevus of Ota with Q-switched Nd:YAG Laser. J Cutan Aesthet Surg. 2013 (PMC full text)
  3. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524-527
  4. IEC 60601-2-22:2019 Ed. 4.0 - Medical electrical equipment, Part 2-22: particular requirements for surgical, cosmetic, therapeutic and diagnostic laser equipment (IEC Webstore)

Bring nevus of ota to your clinic

We will map the right platform, training plan and consumables for your market.